Wave Life Sciences
Drug Discovery

Wave Life Sciences news and milestones

Wave Life Sciences: 10 headlines on record, 7 headlines in the last 90 days. Its story counts 1 milestone.

Data updated Nov 16, 2026 · Back to the company report
10Headlines
7In 90 days
1Milestones

Headlines

Oct 12026
News · YahooFinance
Following meeting with FDA, Wave plans for a single, two-year registrational trial, with a one-year interim analysis for potential accelerated approval based on AATD biomarkers W…
Sep 302026
News · Wave Life Sciences stock gets a USD 12.0 million GSK boost
GSK selected a Wave Life Sciences liver candidate on September 30, 2026, triggering a USD 12.0 million milestone payment. Three more programs are advancing.
Sep 302026
News · markets.businessinsider.com
Candidate selected by GSK utilizes Wave's best-in-class SpiNA design siRNA and triggers a milestone payment to Wave; three additional collaboratio...
Sep 302026
News · YahooFinance
Wave Life Sciences (WVE) said Wednesday that GSK (GSK) selected a liver disease drug candidate from
Sep 232026
News · markets.businessinsider.com
WVE-007 induces fat loss without muscle loss, with clinical data supporting 1-2x per year dosing; preclinical data demonstrate Wave's INHBE GalNAc...
Sep 222026
News · Wave Life Sciences stock hits a 52-week low at USD 4.20
Wave Life Sciences stock traded as low as USD 4.20 on September 22, 2026, before last trading at USD 4.26. Quarterly revenue was USD 2.27 million.
May 6, 20252025
Sources: the outlets named on each headline, each story once

Milestones

Oct 2026
Went public NASDAQ: WVE
Each milestone is dated by its source: registers, filings, the press

How to cite

Wave Life Sciences, News. Alion, Nov 16, 2026. https://alion.io/company/wave-life-sciences/news

.json · .md · CC BY-SA 4.0